to meet FDA safety expectations and regulatory standards.

Step 1: Determine If Your Ingredient Qualifies as an NDI

The first step in the NDI notification process is determining if the ingredient in question qualifies as a new dietary ingredient per FDA definitions. Ingredients that were not present in the market before October 15, 1994, are considered new dietary ingredients. If your ingredient has been on the market before this date, it may not require NDI notification.

The qualification process involves evaluating the ingredient’s history of use in supplements, conventional foods, or any other context. Collecting relevant historical data is essential for establishing its classification. If the ingredient has never been prior marketed, proceed with the NDI notification process.

• Research Ingredient Background: Gather available data about the ingredient’s history of use, any published literature, and industry reports.
• Compile Evidence: Document if any similar products containing the ingredient were sold or used prior to 1994.
• Evaluate Novelty: Assess if the ingredient presents any novel characteristics that could potentially raise safety concerns.

Step 2: Gathering Necessary Documentation

The NDI notification must include comprehensive documentation to demonstrate the safety and intended use of the new ingredient. Below is a list of the key components to collect:

• Toxicology Data: This is fundamental to assessing the safety profile of the ingredient. Gather all available toxicological studies related to your ingredient, including acute, sub-acute, and chronic studies, if available. Ensure these studies conform to Good Laboratory Practices (GLP) as outlined by the FDA.
• History of Use: Compile a dossier of the ingredient’s use in other countries, including any established safety data or regulatory submissions that align with the FDA’s criteria.
• Manufacturing Process: Include details on how the ingredient is manufactured, processed, and prepared. This documentation should cover any critical control points and their significance to the ingredient’s safety.
• Proposed Use: Specify the conditions of use in dietary supplements, including dosing parameters, populations to whom it is marketed, and any adverse events reported.

Step 3: Drafting the NDI Notification

Upon collecting the requisite documentation, begin drafting the NDI notification. The structuring of the notification is essential to ensure clarity and compliance. Below are the components that should be included in your NDI notification:

• Introduction: Briefly introduce the ingredient, its intended use, and the purpose of the document.
• Ingredient Information: Provide the complete name of the ingredient, its chemical composition, and any necessary specifications.
• Safety Information: Detail the toxicology data, including study results, methodologies used in research, and relevance to human consumption. Ensure compliance with FDA safety expectations.
• History of Use: Include information about the ingredient’s previous use or absence thereof, backed with credible evidence as collected during your research.
• Manufacturing Information: Describe the manufacturing process to indicate that it conforms to FDA regulations surrounding Good Manufacturing Practices (GMP).
• Labeling Details: Provide examples of the proposed labeling for the product, making sure to comply with FDA labeling guidelines.

Step 4: Checklist for NDI Notification Submission

To ensure that an NDI notification is thoroughly prepared, utilize the following checklist before submission to the FDA:

• Have all relevant toxicological studies been gathered and included?
• Is there a comprehensive history of use documented?
• Does the notification include data on the manufacturing process compliant with current regulations?
• Has the labeling information been drafted according to FDA requirements?
• Are all statements and claims in compliance with FDA guidelines and devoid of misleading statements?
• Is there proper documentation of consultations with industry experts or consultants about ingredient safety?

Step 5: Submission Process and Communication with the FDA

Once the notification is drafted and the checklist is complete, it can be submitted to the FDA. NDI notifications must be sent to the Office of Dietary Supplement Programs (ODSP). It’s recommended to submit through a secure electronic method to ensure efficient processing.

Upon submission, the FDA will evaluate the notification for safety and compliance with regulatory expectations.

During the review process, clear and open communication with the FDA is essential. Be prepared for follow-up questions or requests for additional information, and ensure that your team can respond promptly to queries from the agency.

Post-Submission Considerations

After the notification is submitted, maintain a detailed record of all communications with the FDA. It is critical to monitor the status of the NDI notification and be responsive to any further inquiries. You may also need to prepare for potential adverse event reporting or additional safety documentation if issues arise after the ingredient is on the market.

Furthermore, companies should keep abreast of evolving regulatory dynamics relative to dietary supplements, especially changes announced by the FDA in guidance documents relating to NDI notifications.

Conclusion

Preparing a robust New Dietary Ingredient (NDI) notification is a multifaceted process that demands comprehensive documentation, adherence to regulatory requirements, and meticulous detail. By following the structured steps outlined in this tutorial and utilizing the provided templates and checklists, regulatory, QA, QC, and compliance professionals can ensure that NDI notifications meet FDA standards and expectations for safety. Proper preparation and compliance will not only facilitate the marketing of innovative dietary ingredients but also uphold industry integrity and consumer trust.